Cargando…
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
The response rate of patients with unresectable liver-limited metastases of colorectal cancer can be improved by converting inoperable disease to operable disease. However, the benefits of conversion chemotherapy for survival are still controversial. Patients considered to have technically inoperabl...
Autores principales: | Basso, Michele, Dadduzio, Vincenzo, Ardito, Francesco, Lombardi, Pasquale, Strippoli, Antonia, Vellone, Maria, Orlandi, Armando, Rossi, Sabrina, Cerchiaro, Eleonora, Cassano, Alessandra, Giuliante, Felice, Barone, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902434/ https://www.ncbi.nlm.nih.gov/pubmed/27196492 http://dx.doi.org/10.1097/MD.0000000000003722 |
Ejemplares similares
-
Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel “sentinel tumor”? A monoinstitutional, STROBE-compliant observational analysis
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2016) -
Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016) -
Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy
por: Quirino, Michela, et al.
Publicado: (2017) -
The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020) -
The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients
por: Tang, Xue-Miao, et al.
Publicado: (2017)